Biolexis Therapeutics

CRO focused on drug discovery of small molecule therapeutics

placeSalt Lake City, Utah, United States calendar_todayFounded 2021 groups10 employees language biolexistx.com

Innovation

5 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 62 times.

YearFilings
20232
20241
20255

Social engagement

Social engagement: 1.8K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; lead investors include Clarke Capital Partners.

Investor typeCountShare
Angel & family office1100%
Coming soon